Sign in

CIK 0001746473

  • Non-accelerated filer
  • Smaller reporting company

PLIANT THERAPEUTICS, INC.

Sign in to watch
Ticker
PLRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474272481
Phone
+1 650-481-6770
Business address
331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-01-26 Coulie Bernard President and CEO Exercise or conversion · Stock Option (right to buy) −15,000 172,380
2023-01-25 Cummings Keith Lamont Chief Financial Officer Grant or award +54,000 138,424
2023-01-25 Cummings Keith Lamont Chief Financial Officer Grant or award · Stock Option (right to buy) +76,200 76,200
2023-01-25 Hull Hans Chief Business Officer Grant or award +54,000 192,191
2023-01-25 Hull Hans Chief Business Officer Grant or award · Stock Option (right to buy) +76,200 76,200
2023-01-25 Ouimette Mike General Counsel & Corp. Sec'y Grant or award +39,000 44,947
2023-01-25 Ouimette Mike General Counsel & Corp. Sec'y Grant or award · Stock Option (right to buy) +55,000 55,000
2023-01-25 Lefebvre Eric Chief Medical Officer Grant or award +57,000 133,926
2023-01-25 Lefebvre Eric Chief Medical Officer Grant or award · Stock Option (right to buy) +80,000 80,000
2023-01-25 Coulie Bernard President and CEO Grant or award +146,300 240,112
2023-01-25 Coulie Bernard President and CEO Grant or award · Stock Option (right to buy) +206,300 206,300
2023-01-25 Coulie Bernard President and CEO Exercise or conversion +15,000 $2.08 $31K 108,812
2023-01-25 Coulie Bernard President and CEO Sale −13,304 $32.40 $431K 95,508
2023-01-25 Coulie Bernard President and CEO Sale −1,696 $33.29 $56K 93,812
2023-01-25 Coulie Bernard President and CEO Exercise or conversion · Stock Option (right to buy) −15,000 202,380
2023-01-24 Coulie Bernard President and CEO Exercise or conversion +15,000 $2.08 $31K 108,812
2023-01-24 Coulie Bernard President and CEO Sale −15,000 $30.89 $463K 93,812
2023-01-24 Coulie Bernard President and CEO Exercise or conversion · Stock Option (right to buy) −15,000 217,380
2023-01-23 Coulie Bernard President and CEO Exercise or conversion +15,000 $2.08 $31K 108,812
2023-01-23 Coulie Bernard President and CEO Sale −10,150 $33.71 $342K 98,662

Page 11 of 19 · 379 trades